Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actual use study of extended-release naproxen sodium in OTC consumers
2014-005268-13Phase 3
- Sponsor
- Bayer
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Aprol in pain, sponsored by Bayer. Primary endpoint: Use Days With One or More Misuse Occasions.
02
Drugs
Aprol
03
Conditions
pain
Beyond the preview
Go deeper on 2014-005268-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005268-13.